Use of a proline-specific endopeptidase to reintroduce gluten in patients with non-coeliac gluten sensitivity: A randomized trial.

MLA

Scricciolo, A., et al. “Use of a Proline-Specific Endopeptidase to Reintroduce Gluten in Patients with Non-Coeliac Gluten Sensitivity: A Randomized Trial.” Clinical Nutrition, vol. 41, no. 9, Sept. 2022, pp. 2025–30. EBSCOhost, https://doi.org/10.1016/j.clnu.2022.07.029.

APA

Scricciolo, A., Lombardo, V., Elli, L., Bascuñán, K. A., Doneda, L., Rinaldi, F., Pinto, D., Araya, M., Costantino, A., Vecchi, M., & Roncoroni, L. (2022). Use of a proline-specific endopeptidase to reintroduce gluten in patients with non-coeliac gluten sensitivity: A randomized trial. Clinical Nutrition, 41(9), 2025–2030. https://doi.org/10.1016/j.clnu.2022.07.029

Chicago

Scricciolo, A., V. Lombardo, L. Elli, K.A. Bascuñán, L. Doneda, F. Rinaldi, D. Pinto, et al. 2022. “Use of a Proline-Specific Endopeptidase to Reintroduce Gluten in Patients with Non-Coeliac Gluten Sensitivity: A Randomized Trial.” Clinical Nutrition 41 (9): 2025–30. doi:10.1016/j.clnu.2022.07.029.